The success of Sildenafil initially drove a surge for major pharmaceutical companies, however recent developments present a murky scenario for those considering a stake. Lower-cost versions are reducing revenue, and https://tayaykup010150.blogdal.com/41602609/viagra-and-pharma-a-risky-bet